Experience with the use of thixagevimab/cilgavimab for pre-exposure prophylaxis of COVID-19 in patients with HIV infection in the Omsk region
Some populations, such as those with HIV infection, may have an inadequate immune response to the coronavirus disease 2019 (COVID-19) vaccine. For these populations, administration of monoclonal antibodies may provide some additional protection. The aim of the study was to evaluate the incidence and...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2023-04-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/1035 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|